Cargando…
Molecular models of NS3 protease variants of the Hepatitis C virus
BACKGROUND: Hepatitis C virus (HCV) currently infects approximately three percent of the world population. In view of the lack of vaccines against HCV, there is an urgent need for an efficient treatment of the disease by an effective antiviral drug. Rational drug design has not been the primary way...
Autores principales: | da Silveira, Nelson JF, Arcuri, Helen A, Bonalumi, Carlos E, de Souza, Fátima P, Mello, Isabel MVGC, Rahal, Paula, Pinho, João RR, de Azevedo, Walter F |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2005
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC547903/ https://www.ncbi.nlm.nih.gov/pubmed/15663787 http://dx.doi.org/10.1186/1472-6807-5-1 |
Ejemplares similares
-
Structural studies of Helicase NS3 variants from Hepatitis C virus genotype 3 in virological sustained responder and non-responder patients
por: Provazzi, Paola JS, et al.
Publicado: (2010) -
New insights regarding HCV-NS5A structure/function and indication of genotypic differences
por: Yamasaki, Lilian HT, et al.
Publicado: (2012) -
SKPDB: a structural database of shikimate pathway enzymes
por: Arcuri, Helen A, et al.
Publicado: (2010) -
Acute hepatitis C virus infection assessment among chronic hemodialysis patients in the Southwest Parana State, Brazil
por: Engel, Maricea, et al.
Publicado: (2007) -
Genetic diversity of NS5A protein from hepatitis C virus genotype 3a and its relationship to therapy response
por: Bittar, Cíntia, et al.
Publicado: (2010)